Progenity Announces Poster Presentations at Digestive Disease Week 2021
24 mai 2021 07h30 HE
|
Progenity, Inc.
SAN DIEGO, May 24, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the presentation of two posters related to the company’s Targeted...
Metacrine to Present New Preclinical Data on MET642 in Inflammatory Bowel Disease at Digestive Disease Week 2021 Virtual Meeting
19 mai 2021 08h05 HE
|
Metacrine, Inc.
SAN DIEGO, May 19, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal...
Progenity to Present Two Abstracts for Novel Ingestible Drug Delivery Technologies at Digestive Disease Week 2021
26 avr. 2021 07h30 HE
|
Progenity, Inc.
SAN DIEGO, April 26, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing...
Flashpoint’s Ronnie Tokazowski Honored by the M3AAWG with JD Falk Award
09 oct. 2018 13h00 HE
|
Flashpoint
NEW YORK, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Flashpoint, the global leader in Business Risk Intelligence (BRI), today announced that Senior Malware Analyst Ronnie Tokazowski has accepted the...
Flashpoint Global Channel Program Welcomes New Talent to Accelerate Growth in EMEA Region
19 sept. 2018 06h00 HE
|
Flashpoint
NEW YORK, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Flashpoint, the global leader in Business Risk Intelligence (BRI), today announced that industry veteran Roy Pickard has joined the company as channel...
Flashpoint Introduces Threat Response & Readiness Subscription
18 juil. 2018 10h02 HE
|
Flashpoint
Flashpoint Professional Service (FPS) helps companies prepare for, as well as, quickly assess and respond to a ransomware or cyber extortion attack NEW YORK, July 18, 2018 (GLOBE NEWSWIRE) --...
RedHill Biopharma to Present Positive Phase II Results of BEKINDA® for IBS-D at Digestive Disease Week 2018
30 mai 2018 08h00 HE
|
RedHill Biopharma Ltd.
TEL-AVIV, Israel and RALEIGH, N.C., May 30, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty...
Flashpoint Accelerates Channel and Strategic Partner Initiatives; Appoints Former IBM Executive Jeff Seifert as Global Channel Chief
02 avr. 2018 10h13 HE
|
Flashpoint
NEW YORK, April 02, 2018 (GLOBE NEWSWIRE) -- Flashpoint, the global leader in Business Risk Intelligence (BRI), today announced that it has appointed former IBM channel executive Jeff Seifert as...
Qu Biologics invited to present Research Data at International Scientific Meetings
03 mai 2017 12h47 HE
|
Qu Biologics
VANCOUVER, British Columbia, May 03, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies...
Sucampo Announces Clinical Data on Lubiprostone to be Presented at Digestive Disease Week
15 mai 2015 16h02 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 15, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that clinical data for lubiprostone will be...